Today we're speaking with Arun Kejariwal, and we will discuss pharmaceutical research and development commercialization in the pharma space. Arun has a lengthy career with all the major leading pharma companies, whether it be Merck, Pfizer, GSK, or Spark Therapeutics, where he is right now as the asset general manager for Huntington's disease and other CNS programs.